Neoadjuvant targeting of glioblastoma multiforme with radiolabeled DOTAGA-substance P - Results from a phase I study

Journal of Neuro-Oncology

Volumn 100, Issue 1, 2010, Pages 129-136

  Cordier, Dominik ^a   Forrer, Flavio ^a   Kneifel, Stefan ^a   Sailer, Martin ^a   Mariani, Luigi ^a   Mäcke, Helmut ^a   Müller Brand, Jan ^a   Merlo, Adrian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Glioblastoma multiforme; Neurokinin receptors; Radiopeptides; Substance P; Targeted therapy; Yttrium 90

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1 GLUTARIC ACID 4,7,10 TRIACETIC ACID SUBSTANCE P I 111; 1,4,7,10 TETRAAZACYCLODODECANE 1 GLUTARIC ACID 4,7,10 TRIACETIC ACID SUBSTANCE P Y 90; ANTIBIOTIC AGENT; CORTICOSTEROID; DEXAMETHASONE; MANNITOL; RADIOPHARMACEUTICAL AGENT; TACHYKININ RECEPTOR; TEMOZOLOMIDE; UNCLASSIFIED DRUG; YTTRIUM 90;

ABSENCE OF SIDE EFFECTS; ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BARTHEL INDEX; BINDING SITE; BRAIN HEMORRHAGE; CEREBROSPINAL FLUID FISTULA; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CRANIOTOMY; DRUG DOSE ESCALATION; DRUG TOLERABILITY; ELECTRON THERAPY; EPIDURAL ABSCESS; EXTERNAL BEAM RADIOTHERAPY; FEASIBILITY STUDY; FEMALE; GLIOBLASTOMA; HUMAN; INTRACRANIAL PRESSURE; MALE; PHASE 1 CLINICAL TRIAL; POSTOPERATIVE CARE; PROGNOSIS; RADIATION DOSE DISTRIBUTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEREOTACTIC BIOPSY; SUBDURAL EMPYEMA; TUMOR VOLUME; WEIGHT GAIN; WOUND DEHISCENCE; WOUND HEALING IMPAIRMENT;

ADULT; AGED; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DIAGNOSTIC IMAGING; FEMALE; FOLLOW-UP STUDIES; GLIOBLASTOMA; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; ORGANOMETALLIC COMPOUNDS; RADIOPHARMACEUTICALS; SUBSTANCE P;

EID: 78650952753     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0153-5     Document Type: Article

References (36)

1. Oertel J, von Buttlar E, Schroeder HW, Gaab MR (2005) Prognosis of gliomas in the 1970s and today. Neurosurg Focus 18:e12
2. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996 (Pubitemid 40349501)
3. Walker MD, Green SB, Byar DP et al (1980) Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303:1323-1329 (Pubitemid 11194457)
4. Hegi ME, Diserens AC, Gorlia T et al (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997-1003 (Pubitemid 40349502)
5. Kreth FW, Berlis A, Spiropoulou V et al (1999) The role of tumor resection in the treatment of glioblastoma multiforme in adults. Cancer 86:2117-2123
6. Hochberg FH, Pruitt A (1980) Assumptions in the radiotherapy of glioblastoma. Neurology 30:907-911 (Pubitemid 10059239)
7. Lacroix M, Abi-Said D, Fourney DR et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190-198 (Pubitemid 32799739)
8. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392-401
9. Sanai N, Berger MS (2008) Glioma extent of resection and its impact on patient outcome. Neurosurgery 62:753-764 (discussion 264-266)
10. Kawakami K, Kawakami M, Kioi M, Husain SR, Puri RK (2004) Distribution kinetics of targeted cytotoxin in glioma by bolus or convection-enhanced delivery in a murine model. J Neurosurg 101:1004-1011 (Pubitemid 43186453)
11. Rand RW, Kreitman RJ, Patronas N, Varricchio F, Pastan I, Puri RK (2000) Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma. Clin Cancer Res 6:2157-2165 (Pubitemid 30399180)
12. Cokgor I, Akabani G, Kuan CT et al (2000) Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas. J Clin Oncol 18:3862-3872
13. Laske DW, Youle RJ, Oldfield EH (1997) Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nat Med 3:1362-1368 (Pubitemid 28011036)
14. Maecke HR (2005) Radiolabeled peptides in nuclear oncology: influence of peptide structure and labeling strategy on pharmacology. Ernst Schering Res Found Workshop 46:43-72
15. Boyd M, Mairs RJ, Keith WN et al (2004) An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radioastatine and harnessing radiation-mediated bystander effects. J Gene Med 6:937-947 (Pubitemid 40228109)
16. Kneifel S, Cordier D, Good S et al (2006) Local targeting of malignant gliomas by the diffusible peptidic vector 1,4,7,10-tetraazacyclododecane-1- glutaric acid-4,7,10-triacetic acid-substance P. Clin Cancer Res 12:3843-3850
17. Hennig IM, Laissue JA, Horisberger U, Reubi JC (1995) Substance-P receptors in human primary neoplasms: tumoral and vascular localization. Int J Cancer 61:786-792
18. de Bouard S, Herlin P, Christensen JG et al (2007) Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma. Neuro Oncol 9:412-423
19. Fischer I, Gagner JP, Law M, Newcomb EW, Zagzag D (2005) Angiogenesis in gliomas: biology and molecular pathophysiology. Brain Pathol 15:297-310
20. Puduvalli VK, Giglio P, Groves MD et al (2008) Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme. Neuro Oncol 10:216-222
21. Monga DK, O'Connell MJ (2006) Surgical adjuvant therapy for colorectal cancer: current approaches and future directions. Ann Surg Oncol 13:1021-1034 (Pubitemid 44337961)
22. Pahlman L, Glimelius B (1990) Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg 211:187-195
23. Bhatnagar AS (2006) Review of the development of letrozole and its use in advanced breast cancer and in the neoadjuvant setting. Breast 15(Suppl 1):S3-S13
24. Sachelarie I, Grossbard ML, Chadha M, Feldman S, Ghesani M, Blum RH (2006) Primary systemic therapy of breast cancer. Oncologist 11:574-589 (Pubitemid 43967613)
25. de Vries NA, Beijnen JH, Boogerd W, van Tellingen O (2006) Blood-brain barrier and chemotherapeutic treatment of brain tumors. Expert Rev Neurother 6:1199-1209 (Pubitemid 44231977)
26. Fukumura D, Jain RK (2007) Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J Cell Biochem 101:937-949 (Pubitemid 47040874)
27. Sangha H, Lipson D, Foley N et al (2005) A comparison of the Barthel Index and the Functional Independence Measure as outcome measures in stroke rehabilitation: patterns of disability scale usage in clinical trials. Int J Rehabil Res 28:135-139 (Pubitemid 43193769)
28. Merlo A, Hausmann O, Wasner M et al (1999) Locoregional regulatory peptide receptor targeting with the diffusible somatostatin analogue 90Y-labeled DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC): a pilot study in human gliomas. Clin Cancer Res 5:1025-1033 (Pubitemid 29233216)
29. Merlo A, Jermann E, Hausmann O et al (1997) Biodistribution of 111In-labelled SCN-bz-DTPA-BC-2 MAb following loco-regional injection into glioblastomas. Int J Cancer 71:810-816 (Pubitemid 27237203)
30. Schumacher T, Hofer S, Eichhorn K et al (2002) Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study. Eur J Nucl Med Mol Imaging 29:486-493
31. Kneifel S, Bernhardt P, Uusijarvi H et al (2007) Individual voxel-wise dosimetry of targeted 90Y-labelled substance P radiotherapy for malignant gliomas. Eur J Nucl MedMol Imaging 34:1388-1395 (Pubitemid 47312574)
32. Sims E, Doughty D, Macaulay E et al (1999) Stereotactically delivered cranial radiation therapy: a ten-year experience of linac-based radiosurgery in the UK. Clin Oncol (R Coll Radiol) 11:303-320
33. Singh VP, Kansai S, Vaishya S, Julka PK, Mehta VS (2000) Early complications following gamma knife radiosurgery for intracranial meningiomas. J Neurosurg 93(Suppl 3):57-61 (Pubitemid 32799546)
34. Takenaka N, Imanishi T, Sasaki H et al (2003) Delayed radiation necrosis with extensive brain edema after gamma knife radiosurgery for multiple cerebral cavernous malformations-case report. Neurol Med Chir (Tokyo) 43:391-395 (Pubitemid 37071222)
35. Fahlbusch R, Nimsky C (2005) Intraoperative MRI developments. Neurosurg Clin N Am 16:xi-xiii
36. Nimsky C, Ganslandt O, Fahlbusch R (2004) Functional neuronavigation and intraoperative MRI. Adv Tech Stand Neurosurg 29:229-263